The Antispasmodics Drugs Market is expected to register a CAGR of 8.5% from 2025 to 2031, with a market size expanding from US$ XX million in 2024 to US$ XX Million by 2031.
The Antispasmodics Drugs Market report is segmented by product type into Prednisolone, Triamcinolone, Prednisone, Methylprednisolone, and Dexamethasone. The route of administration segment includes Intramuscular, Intra-articular, Intravenous, and Epidural. The distribution channel segment includes Hospital Pharmacy, Specialty Clinics, and Retail Pharmacy & Drug Stores. The market evaluation is presented in US$ for the above segmental analysis. The global analysis is broken down at the regional level and major countries. The market evaluation is presented in US$ for the above segmental analysis.
Purpose of the ReportThe report Antispasmodics Drugs Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:
- Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
- Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
- Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.
Antispasmodics Drugs Market Segmentation
Product Type- Prednisolone
- Triamcinolone
- Prednisone
- Methylprednisolone
- Dexamethasone
- Intramuscular
- Intra-articular
- Intravenous
- Epidural
- Hospital pharmacy
- Specialty clinics
- Retail pharmacy & drug stores
- North America
- Europe
- Asia-Pacific
- South and Central America
- Middle East and Africa
Strategic Insights
Antispasmodics Drugs Market Growth Drivers- Rising Prevalence of Gastrointestinal Conditions: Rising prevalence of different conditions, such as irritable bowel syndrome, and gastroesophageal reflux disease, among others are a few of the most critical reasons for the growth in the market.
- Increasing Aging Population: An increasing trend in age within the global population will further increase cases of these conditions, and there would be an increase in the demand for antispasmodic medications.
- Rising Healthcare Expenditure and Disposable Incomes in Emerging Economies: Rising healthcare expenditure and increasing disposable incomes in the emerging economies are opening up new opportunities for the antispasmodic drugs market.
- Personalized Medicine and Tailored Treatment: Among the most important trends shortly is personalized medicine, where a treatment regimen is tailored for individual patients. This may be one of the factors shaping novel antispasmodic drugs that are more effective and show fewer side effects.
- Adoption of Digital Health Technologies: The adoption rate of digital health technologies such as telemedicine and wearable devices is likely to improve monitoring and remote management of chronic disorders, thus driving demand in the market for antispasmodic drugs.
- Expansion of Healthcare Infrastructure: This is also supplemented by an expansion in healthcare infrastructure in emerging countries, along with increased healthcare expenditure. With an increasing percentage of elderly people in the total world population, the demand for antispasmodic drugs is expected to increase due to increased gastrointestinal disorders.
- Rising Prevalence of Gastrointestinal Disorders:
The increasing incidence of gastrointestinal diseases, such as irritable bowel syndrome (IBS), boosts the demand for effective antispasmodic treatments.
- Growing Awareness of Chronic Pain Management:
Heightened awareness and focus on managing chronic pain conditions create opportunities for antispasmodic drugs in pain relief therapies.
- Advancements in Drug Formulation:
Innovations in drug delivery systems and formulations enhance the efficacy and patient compliance of antispasmodic medications, expanding market potential.
Market Report Scope
Key Selling Points
- Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Antispasmodics Drugs Market, providing a holistic landscape.
- Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
- Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
- Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.
The research report on the Antispasmodics Drugs Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.
REGIONAL FRAMEWORK
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The leading players of the market are: Allergan, Hikma Pharmaceuticals, Lannett, Mylan N.V., Nexus Pharmaceuticals, Akorn Incorporated, Aurobindo Pharma, Daiichi Sankyo, Inc, Fresenius Kabi Ag, Shanghai Fosun Pharmaceutical (Group) Co., Ltd, SunGen Pharma LLC, Others
The report can be delivered in PDF/PPT format; we can also share excel dataset based on the request.
Some of the customization options available based on request are additional 3–5 company profiles and country-specific analysis of 3–5 countries of your choice. Customizations are to be requested/discussed before making final order confirmation, as our team would review the same and check the feasibility.
Digital health technologies, such as telemedicine and wearable devices, are enhancing patient monitoring and remote management of chronic conditions. The future of the antispasmodic drugs market is shaped by several emerging trends. Personalized medicine, tailoring treatments to individual patient needs, is driving the development of targeted therapies. New opportunities are emerging due to an aging population and rising healthcare expenditure in emerging markets. Also, advancements in drug delivery systems, as well as focus on combination therapies, will also drive the market growth forward.
Antispasmodics Drugs Market is expected to grow at a CAGR of 8.5% between 2023-2031
The primary driver for the antispasmodic drugs market is the increasing prevalence of gastrointestinal disorders, including irritable bowel syndrome (IBS), gastroesophageal reflux disease (GERD), and peptic ulcers. These conditions are on the rise due to the aging population and increased stress levels and unhealthy lifestyles. Moreover, increased awareness about these disorders and the availability of effective treatment options are driving the market forward. Furthermore, growing healthcare expenses and rising disposable incomes in developing countries are providing new opportunities for the antispasmodic drugs market.
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Softgel Capsules Market - By Product Type
1.3.2 Softgel Capsules Market - By Raw Material
1.3.3 Softgel Capsules Market - By Application
1.3.4 Softgel Capsules Market - By End User
1.3.5 Softgel Capsules Market - By Region
1.3.5.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. SOFTGEL CAPSULES MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. SOFTGEL CAPSULES MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. SOFTGEL CAPSULES MARKET - GLOBAL MARKET ANALYSIS
6.1. SOFTGEL CAPSULES - GLOBAL MARKET OVERVIEW
6.2. SOFTGEL CAPSULES - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. SOFTGEL CAPSULES MARKET - REVENUE AND FORECASTS TO 2028 - PRODUCT TYPE
7.1. OVERVIEW
7.2. PRODUCT TYPE MARKET FORECASTS AND ANALYSIS
7.3. GELATIN SOFTGEL CAPSULES
7.3.1. Overview
7.3.2. Gelatin Softgel Capsules Market Forecast and Analysis
7.4. VEGETARIAN SOFTGEL CAPSULES
7.4.1. Overview
7.4.2. Vegetarian Softgel Capsules Market Forecast and Analysis
8. SOFTGEL CAPSULES MARKET - REVENUE AND FORECASTS TO 2028 - RAW MATERIAL
8.1. OVERVIEW
8.2. RAW MATERIAL MARKET FORECASTS AND ANALYSIS
8.3. TYPE-A GELATIN (PORK SKIN)
8.3.1. Overview
8.3.2. Type-A Gelatin (Pork Skin) Market Forecast and Analysis
8.4. TYPE-B GELATIN (ANIMAL BONES & CALF SKIN)
8.4.1. Overview
8.4.2. Type-B Gelatin (Animal Bones & Calf Skin) Market Forecast and Analysis
8.5. FISH BONE GELATIN
8.5.1. Overview
8.5.2. Fish Bone Gelatin Market Forecast and Analysis
8.6. HYDROXY PROPYL METHYL CELLULOSE (HPMC)
8.6.1. Overview
8.6.2. Hydroxy Propyl Methyl Cellulose (HPMC) Market Forecast and Analysis
8.7. STARCH MATERIAL
8.7.1. Overview
8.7.2. Starch Material Market Forecast and Analysis
8.8. PULLULAN
8.8.1. Overview
8.8.2. Pullulan Market Forecast and Analysis
9. SOFTGEL CAPSULES MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
9.1. OVERVIEW
9.2. APPLICATION MARKET FORECASTS AND ANALYSIS
9.3. ANTACID & ANTIFLATULENT PREPARATIONS
9.3.1. Overview
9.3.2. Antacid & Antiflatulent Preparations Market Forecast and Analysis
9.4. ANTIANEMIC PREPARATIONS (HEMATENIC PREPARATIONS)
9.4.1. Overview
9.4.2. Antianemic Preparations (Hematenic Preparations) Market Forecast and Analysis
9.5. ANTI-INFLAMMATORY DRUGS
9.5.1. Overview
9.5.2. Anti-inflammatory Drugs Market Forecast and Analysis
9.6. ANTIBIOTIC & ANTIBACTERIAL DRUGS
9.6.1. Overview
9.6.2. Antibiotic & Antibacterial Drugs Market Forecast and Analysis
9.7. COUGH & COLD PREPARATIONS
9.7.1. Overview
9.7.2. Cough & Cold Preparations Market Forecast and Analysis
9.8. CARDIOVASCULAR THERAPY DRUGS
9.8.1. Overview
9.8.2. Cardiovascular Therapy Drugs Market Forecast and Analysis
9.9. VITAMIN AND DIETARY SUPPLEMENTS
9.9.1. Overview
9.9.2. Vitamin and Dietary Supplements Market Forecast and Analysis
9.10. OTHERS
9.10.1. Overview
9.10.2. Others Market Forecast and Analysis
10. SOFTGEL CAPSULES MARKET - REVENUE AND FORECASTS TO 2028 - END USER
10.1. OVERVIEW
10.2. END USER MARKET FORECASTS AND ANALYSIS
10.3. PHARMACEUTICAL COMPANIES
10.3.1. Overview
10.3.2. Pharmaceutical Companies Market Forecast and Analysis
10.4. NUTRACEUTICAL COMPANIES
10.4.1. Overview
10.4.2. Nutraceutical Companies Market Forecast and Analysis
10.5. COSMECEUTICAL COMPANIES
10.5.1. Overview
10.5.2. Cosmeceutical Companies Market Forecast and Analysis
10.6. CONTRACT MANUFACTURING ORGANIZATIONS
10.6.1. Overview
10.6.2. Contract Manufacturing Organizations Market Forecast and Analysis
11. SOFTGEL CAPSULES MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
11.1. NORTH AMERICA
11.1.1 North America Softgel Capsules Market Overview
11.1.2 North America Softgel Capsules Market Forecasts and Analysis
11.1.3 North America Softgel Capsules Market Forecasts and Analysis - By Product Type
11.1.4 North America Softgel Capsules Market Forecasts and Analysis - By Raw Material
11.1.5 North America Softgel Capsules Market Forecasts and Analysis - By Application
11.1.6 North America Softgel Capsules Market Forecasts and Analysis - By End User
11.1.7 North America Softgel Capsules Market Forecasts and Analysis - By Countries
11.1.7.1 United States Softgel Capsules Market
11.1.7.1.1 United States Softgel Capsules Market by Product Type
11.1.7.1.2 United States Softgel Capsules Market by Raw Material
11.1.7.1.3 United States Softgel Capsules Market by Application
11.1.7.1.4 United States Softgel Capsules Market by End User
11.1.7.2 Canada Softgel Capsules Market
11.1.7.2.1 Canada Softgel Capsules Market by Product Type
11.1.7.2.2 Canada Softgel Capsules Market by Raw Material
11.1.7.2.3 Canada Softgel Capsules Market by Application
11.1.7.2.4 Canada Softgel Capsules Market by End User
11.1.7.3 Mexico Softgel Capsules Market
11.1.7.3.1 Mexico Softgel Capsules Market by Product Type
11.1.7.3.2 Mexico Softgel Capsules Market by Raw Material
11.1.7.3.3 Mexico Softgel Capsules Market by Application
11.1.7.3.4 Mexico Softgel Capsules Market by End User
11.1.7.4 US Softgel Capsules Market
11.1.7.4.1 US Softgel Capsules Market by Product Type
11.1.7.4.2 US Softgel Capsules Market by Raw Material
11.1.7.4.3 US Softgel Capsules Market by Application
11.1.7.4.4 US Softgel Capsules Market by End User
11.2. EUROPE
11.2.1 Europe Softgel Capsules Market Overview
11.2.2 Europe Softgel Capsules Market Forecasts and Analysis
11.2.3 Europe Softgel Capsules Market Forecasts and Analysis - By Product Type
11.2.4 Europe Softgel Capsules Market Forecasts and Analysis - By Raw Material
11.2.5 Europe Softgel Capsules Market Forecasts and Analysis - By Application
11.2.6 Europe Softgel Capsules Market Forecasts and Analysis - By End User
11.2.7 Europe Softgel Capsules Market Forecasts and Analysis - By Countries
11.2.7.1 Germany Softgel Capsules Market
11.2.7.1.1 Germany Softgel Capsules Market by Product Type
11.2.7.1.2 Germany Softgel Capsules Market by Raw Material
11.2.7.1.3 Germany Softgel Capsules Market by Application
11.2.7.1.4 Germany Softgel Capsules Market by End User
11.2.7.2 France Softgel Capsules Market
11.2.7.2.1 France Softgel Capsules Market by Product Type
11.2.7.2.2 France Softgel Capsules Market by Raw Material
11.2.7.2.3 France Softgel Capsules Market by Application
11.2.7.2.4 France Softgel Capsules Market by End User
11.2.7.3 Italy Softgel Capsules Market
11.2.7.3.1 Italy Softgel Capsules Market by Product Type
11.2.7.3.2 Italy Softgel Capsules Market by Raw Material
11.2.7.3.3 Italy Softgel Capsules Market by Application
11.2.7.3.4 Italy Softgel Capsules Market by End User
11.2.7.4 Spain Softgel Capsules Market
11.2.7.4.1 Spain Softgel Capsules Market by Product Type
11.2.7.4.2 Spain Softgel Capsules Market by Raw Material
11.2.7.4.3 Spain Softgel Capsules Market by Application
11.2.7.4.4 Spain Softgel Capsules Market by End User
11.2.7.5 United Kingdom Softgel Capsules Market
11.2.7.5.1 United Kingdom Softgel Capsules Market by Product Type
11.2.7.5.2 United Kingdom Softgel Capsules Market by Raw Material
11.2.7.5.3 United Kingdom Softgel Capsules Market by Application
11.2.7.5.4 United Kingdom Softgel Capsules Market by End User
11.3. ASIA-PACIFIC
11.3.1 Asia-Pacific Softgel Capsules Market Overview
11.3.2 Asia-Pacific Softgel Capsules Market Forecasts and Analysis
11.3.3 Asia-Pacific Softgel Capsules Market Forecasts and Analysis - By Product Type
11.3.4 Asia-Pacific Softgel Capsules Market Forecasts and Analysis - By Raw Material
11.3.5 Asia-Pacific Softgel Capsules Market Forecasts and Analysis - By Application
11.3.6 Asia-Pacific Softgel Capsules Market Forecasts and Analysis - By End User
11.3.7 Asia-Pacific Softgel Capsules Market Forecasts and Analysis - By Countries
11.3.7.1 Australia Softgel Capsules Market
11.3.7.1.1 Australia Softgel Capsules Market by Product Type
11.3.7.1.2 Australia Softgel Capsules Market by Raw Material
11.3.7.1.3 Australia Softgel Capsules Market by Application
11.3.7.1.4 Australia Softgel Capsules Market by End User
11.3.7.2 China Softgel Capsules Market
11.3.7.2.1 China Softgel Capsules Market by Product Type
11.3.7.2.2 China Softgel Capsules Market by Raw Material
11.3.7.2.3 China Softgel Capsules Market by Application
11.3.7.2.4 China Softgel Capsules Market by End User
11.3.7.3 India Softgel Capsules Market
11.3.7.3.1 India Softgel Capsules Market by Product Type
11.3.7.3.2 India Softgel Capsules Market by Raw Material
11.3.7.3.3 India Softgel Capsules Market by Application
11.3.7.3.4 India Softgel Capsules Market by End User
11.3.7.4 Japan Softgel Capsules Market
11.3.7.4.1 Japan Softgel Capsules Market by Product Type
11.3.7.4.2 Japan Softgel Capsules Market by Raw Material
11.3.7.4.3 Japan Softgel Capsules Market by Application
11.3.7.4.4 Japan Softgel Capsules Market by End User
11.3.7.5 South Korea Softgel Capsules Market
11.3.7.5.1 South Korea Softgel Capsules Market by Product Type
11.3.7.5.2 South Korea Softgel Capsules Market by Raw Material
11.3.7.5.3 South Korea Softgel Capsules Market by Application
11.3.7.5.4 South Korea Softgel Capsules Market by End User
11.4. MIDDLE EAST AND AFRICA
11.4.1 Middle East and Africa Softgel Capsules Market Overview
11.4.2 Middle East and Africa Softgel Capsules Market Forecasts and Analysis
11.4.3 Middle East and Africa Softgel Capsules Market Forecasts and Analysis - By Product Type
11.4.4 Middle East and Africa Softgel Capsules Market Forecasts and Analysis - By Raw Material
11.4.5 Middle East and Africa Softgel Capsules Market Forecasts and Analysis - By Application
11.4.6 Middle East and Africa Softgel Capsules Market Forecasts and Analysis - By End User
11.4.7 Middle East and Africa Softgel Capsules Market Forecasts and Analysis - By Countries
11.4.7.1 South Africa Softgel Capsules Market
11.4.7.1.1 South Africa Softgel Capsules Market by Product Type
11.4.7.1.2 South Africa Softgel Capsules Market by Raw Material
11.4.7.1.3 South Africa Softgel Capsules Market by Application
11.4.7.1.4 South Africa Softgel Capsules Market by End User
11.4.7.2 Saudi Arabia Softgel Capsules Market
11.4.7.2.1 Saudi Arabia Softgel Capsules Market by Product Type
11.4.7.2.2 Saudi Arabia Softgel Capsules Market by Raw Material
11.4.7.2.3 Saudi Arabia Softgel Capsules Market by Application
11.4.7.2.4 Saudi Arabia Softgel Capsules Market by End User
11.4.7.3 U.A.E Softgel Capsules Market
11.4.7.3.1 U.A.E Softgel Capsules Market by Product Type
11.4.7.3.2 U.A.E Softgel Capsules Market by Raw Material
11.4.7.3.3 U.A.E Softgel Capsules Market by Application
11.4.7.3.4 U.A.E Softgel Capsules Market by End User
11.5. SOUTH AND CENTRAL AMERICA
11.5.1 South and Central America Softgel Capsules Market Overview
11.5.2 South and Central America Softgel Capsules Market Forecasts and Analysis
11.5.3 South and Central America Softgel Capsules Market Forecasts and Analysis - By Product Type
11.5.4 South and Central America Softgel Capsules Market Forecasts and Analysis - By Raw Material
11.5.5 South and Central America Softgel Capsules Market Forecasts and Analysis - By Application
11.5.6 South and Central America Softgel Capsules Market Forecasts and Analysis - By End User
11.5.7 South and Central America Softgel Capsules Market Forecasts and Analysis - By Countries
11.5.7.1 Brazil Softgel Capsules Market
11.5.7.1.1 Brazil Softgel Capsules Market by Product Type
11.5.7.1.2 Brazil Softgel Capsules Market by Raw Material
11.5.7.1.3 Brazil Softgel Capsules Market by Application
11.5.7.1.4 Brazil Softgel Capsules Market by End User
11.5.7.2 Argentina Softgel Capsules Market
11.5.7.2.1 Argentina Softgel Capsules Market by Product Type
11.5.7.2.2 Argentina Softgel Capsules Market by Raw Material
11.5.7.2.3 Argentina Softgel Capsules Market by Application
11.5.7.2.4 Argentina Softgel Capsules Market by End User
12. IMPACT OF COVID-19 PANDEMIC ON GLOBAL SOFTGEL CAPSULES MARKET
12.1 North America
12.2 Europe
12.3 Asia-Pacific
12.4 Rest of the World
13. INDUSTRY LANDSCAPE
13.1. MERGERS AND ACQUISITIONS
13.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
13.3. NEW PRODUCT LAUNCHES
13.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
14. SOFTGEL CAPSULES MARKET, KEY COMPANY PROFILES
14.1. AENOVA GROUP GMBH
14.1.1. Key Facts
14.1.2. Business Description
14.1.3. Products and Services
14.1.4. Financial Overview
14.1.5. SWOT Analysis
14.1.6. Key Developments
14.2. HUNAN ER-KANG PHARMACEUTICAL CO., LTD
14.2.1. Key Facts
14.2.2. Business Description
14.2.3. Products and Services
14.2.4. Financial Overview
14.2.5. SWOT Analysis
14.2.6. Key Developments
14.3. CAPSUGEL
14.3.1. Key Facts
14.3.2. Business Description
14.3.3. Products and Services
14.3.4. Financial Overview
14.3.5. SWOT Analysis
14.3.6. Key Developments
14.4. FUJI CAPSULE CO., LTD.
14.4.1. Key Facts
14.4.2. Business Description
14.4.3. Products and Services
14.4.4. Financial Overview
14.4.5. SWOT Analysis
14.4.6. Key Developments
14.5. SIRIO PHARMA COMPANY LIMITED
14.5.1. Key Facts
14.5.2. Business Description
14.5.3. Products and Services
14.5.4. Financial Overview
14.5.5. SWOT Analysis
14.5.6. Key Developments
14.6. CAPTEK SOFTGEL INTERNATIONAL INC
14.6.1. Key Facts
14.6.2. Business Description
14.6.3. Products and Services
14.6.4. Financial Overview
14.6.5. SWOT Analysis
14.6.6. Key Developments
14.7. CATALENT, INC.
14.7.1. Key Facts
14.7.2. Business Description
14.7.3. Products and Services
14.7.4. Financial Overview
14.7.5. SWOT Analysis
14.7.6. Key Developments
14.8. EUROCAPS LTD (PART OF DCC PLC)
14.8.1. Key Facts
14.8.2. Business Description
14.8.3. Products and Services
14.8.4. Financial Overview
14.8.5. SWOT Analysis
14.8.6. Key Developments
14.9. GUANGDONG YICHAO BIOLOGICAL CO., LTD
14.9.1. Key Facts
14.9.2. Business Description
14.9.3. Products and Services
14.9.4. Financial Overview
14.9.5. SWOT Analysis
14.9.6. Key Developments
14.10. ELNOVA PHARMA
14.10.1. Key Facts
14.10.2. Business Description
14.10.3. Products and Services
14.10.4. Financial Overview
14.10.5. SWOT Analysis
14.10.6. Key Developments
14.11. OTHERS
14.11.1. Key Facts
14.11.2. Business Description
14.11.3. Products and Services
14.11.4. Financial Overview
14.11.5. SWOT Analysis
14.11.6. Key Developments
15. APPENDIX
15.1. ABOUT THE INSIGHT PARTNERS
15.2. GLOSSARY OF TERMS
1. Allergan
2. Hikma Pharmaceuticals
3. Lannett
4. Mylan N.V.
5. Nexus Pharmaceuticals
6. Akorn Incorporated
7. Aurobindo Pharma
8. Daiichi Sankyo, Inc
9. Fresenius Kabi Ag
10. Shanghai Fosun Pharmaceutical (Group) Co., Ltd
11. SunGen Pharma LLC
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For